XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Parent [Member]
Beginning balance at Dec. 31, 2020 $ 56,197,957 $ 56,197,957 $ (68,410,028)
Beginning balance, shares at Dec. 31, 2020 64,515,231      
Common stock issued pursuant to offerings $ 754,464 754,464    
Common stock issued pursuant to offerings, shares 62,873      
Common stock issued pursuant to services $ 101,250 101,250    
Common stock issued pursuant to services, shares 35,000      
Common stock issued pursuant to conversion of preferred stock $ 50,000 50,000    
Common stock issued pursuant to conversion of preferred stock, shares 200,000      
Common stock issued pursuant to exercise of options    
Common stock issued pursuant to exercise of options, shares      
Common stock issued pursuant to cashless exercise of warrants, shares 21,250      
Common stock issued pursuant to antidilutive provisions  
Common stock issued pursuant to antidilutive provisions, shares      
Stock-based compensation $ 86,193 86,193    
Net loss     (986,939)
Non-controlling interest      
Preferred Dividends     (32,552)  
Ending balance at Mar. 31, 2021 $ 57,189,864 57,189,864 (69,429,519) (12,239,655)
Ending balance, shares at Mar. 31, 2021 64,834,354      
Beginning balance at Dec. 31, 2021 $ 70,880,386 70,880,386 (74,269,898)
Beginning balance, shares at Dec. 31, 2021 66,295,288      
Common stock issued pursuant to offerings $ 20,552,000 20,552,000    
Common stock issued pursuant to offerings, shares 1,650,000      
Common stock issued pursuant to services $ 5,717,010 5,717,010    
Common stock issued pursuant to services, shares 448,409      
Common stock issued pursuant to conversion of preferred stock $ 2,494,134 2,494,134    
Common stock issued pursuant to conversion of preferred stock, shares 9,976,536      
Common stock issued pursuant to exercise of options $ 210,000 210,000    
Common stock issued pursuant to exercise of options, shares 200,000      
Common stock issued pursuant to cashless exercise of warrants, shares 311,750      
Common stock issued pursuant to antidilutive provisions $ 4,691,022 4,691,022 (4,691,022)  
Common stock issued pursuant to antidilutive provisions, shares 335,073      
Stock-based compensation $ 3,050,883 3,050,883    
Net loss     (11,858,364)
Non-controlling interest     (35,442)  
Preferred Dividends     (21,232)  
Ending balance at Mar. 31, 2022 $ 107,595,436 $ 107,595,436 $ (90,875,958) $ 16,719,478
Ending balance, shares at Mar. 31, 2022 79,217,056